Kuriakose Emil 4
4 · Terns Pharmaceuticals, Inc. · Filed Jul 3, 2025
Insider Transaction Report
Form 4
Kuriakose Emil
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-07-01$4.27/sh−853$3,640→ 52,464 total
Footnotes (2)
- [F1]Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person.
- [F2]This sale price represents the weighted average sale price of the shares sold ranging from $4.215 to $4.32 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.